At a glance
- Originator Merck & Co
- Class Antiallergics; Antiasthmatics; Antiulcers
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Peptic ulcer
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Peptic ulcer in United Kingdom (PO)
- 21 Oct 1996 L 649923 is being investigated for use in Peptic Ulcer Disease
- 21 Oct 1996 Preclinical development for Peptic ulcer in United Kingdom (PO)